BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 19726940)

  • 21. Spatio-temporal selectivity of loss of colour and luminance contrast sensitivity with multiple sclerosis and optic neuritis.
    Flanagan P; Markulev C
    Ophthalmic Physiol Opt; 2005 Jan; 25(1):57-65. PubMed ID: 15649184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Color adaptation in a yellow-blue system: proof of a simple numerical relationship].
    Bäuml KH
    Z Psychol Z Angew Psychol; 1991; 199(3):251-65. PubMed ID: 1685607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene-environment interactions and aging visual function: a classical twin study.
    Hogg RE; Dimitrov PN; Dirani M; Varsamidis M; Chamberlain MD; Baird PN; Guymer RH; Vingrys AJ
    Ophthalmology; 2009 Feb; 116(2):263-9. PubMed ID: 19019448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex-related differences in chromatic sensitivity.
    Rodríguez-Carmona M; Sharpe LT; Harlow JA; Barbur JL
    Vis Neurosci; 2008; 25(3):433-40. PubMed ID: 18598414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromatic-contrast threshold impairment in diabetes.
    Tregear SJ; Knowles PJ; Ripley LG; Casswell AG
    Eye (Lond); 1997; 11 ( Pt 4)():537-46. PubMed ID: 9425421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visual hallucinations during visual recovery after central retinal artery occlusion.
    Tan CS; Sabel BA; Goh KY
    Arch Neurol; 2006 Apr; 63(4):598-600. PubMed ID: 16606776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poor visual discrimination and visual hallucinations in Parkinson's disease.
    Diederich NJ; Goetz CG; Raman R; Pappert EJ; Leurgans S; Piery V
    Clin Neuropharmacol; 1998; 21(5):289-95. PubMed ID: 9789709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vision rehabilitation and Charles Bonnet Syndrome.
    Crumbliss KE; Taussig MJ; Jay WM
    Semin Ophthalmol; 2008; 23(2):121-6. PubMed ID: 18320478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-related ocular microangiopathic syndrome and color contrast sensitivity.
    Geier SA; Hammel G; Bogner JR; Kronawitter U; Berninger T; Goebel FD
    Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):3011-21. PubMed ID: 8206718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test.
    Moura AL; Teixeira RA; Oiwa NN; Costa MF; Feitosa-Santana C; Callegaro D; Hamer RD; Ventura DF
    Vis Neurosci; 2008; 25(3):463-8. PubMed ID: 18598419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The characteristics of luminance of color visual evoked potential in macular diseases].
    Wang Z; Wu L; Wu D; Liang J
    Zhonghua Yan Ke Za Zhi; 1999 Nov; 35(6):430-3. PubMed ID: 11835853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neural basis of photo/chromatic sensitivity in adolescence.
    Yamasaki T; Goto Y; Kinukawa N; Tobimatsu S
    Epilepsia; 2008 Sep; 49(9):1611-8. PubMed ID: 18410364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a chromatometer: a new method for blue-yellow or green-red visual comparisons, and anomaly screening techniques.
    Gaudart J; Pétrakian JP
    Med Sci Monit; 2005 Aug; 11(8):MT39-52. PubMed ID: 16049389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual evoked potentials for reversals of red-green gratings with different chromatic contrasts: asymmetries with respect to isoluminance.
    Rudvin I
    Vis Neurosci; 2005; 22(6):749-58. PubMed ID: 16469185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of chromatic, spatial, and temporal sensitivity in optic nerve disease.
    Grigsby SS; Vingrys AJ; Benes SC; King-Smith PE
    Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3252-62. PubMed ID: 1748555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Visual hallucinations in Parkinson and Charles Bonnet Syndrome patients. A phenomenological and pathogenetic comparison].
    Diederich NJ; Pieri V; Goetz CG
    Fortschr Neurol Psychiatr; 2000 Mar; 68(3):129-36. PubMed ID: 10758844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contrast sensitivity of visually handicapped patients].
    Lindner H; Behrens-Baumann W
    Ophthalmologe; 1995 Apr; 92(2):137-41. PubMed ID: 7780271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Color vision defect type and spatial vision in the optic neuritis treatment trial.
    Schneck ME; Haegerstrom-Portnoy G
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2278-89. PubMed ID: 9344351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Categorical color naming of surface color codes by people with abnormal color vision.
    Cole BL; Lian KY; Sharpe K; Lakkis C
    Optom Vis Sci; 2006 Dec; 83(12):879-86. PubMed ID: 17164680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Color discrimination, color naming and color preferences in 80-year olds.
    Wijk H; Berg S; Sivik L; Steen B
    Aging (Milano); 1999 Jun; 11(3):176-85. PubMed ID: 10476313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.